University of Michigan researchers Sriram Chandrasekaran and Danai Koutra are using AI to rethink how drug combinations are identified for complex diseases like cancer and infections. Their approach challenges traditional models in computational drug discovery. Read the full article to learn more about their groundbreaking work.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.